The Indian government is considering regulatory revisions for the MedTech and pharma sectors and has sought input from the industry. Niti Aayog member VK Paul highlighted the need to update the regulatory framework to support advancements in medical technology and pharma, aiming for enhanced exports and innovation.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QyVP3OY
via IFTTT
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment